| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Oxygen | FAERS: 9 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 2 | Fentanyl | FAERS: 3 | US FAERS | |
| 3 | Pregabalin | FAERS: 3 | US FAERS | |
| 4 | ambrisentan | FAERS: 3 | US FAERS | |
| 5 | 2-[(E)-[1-(2-Amino-1,3-thiazol-4-yl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-2-methylpropanoic acid;(2S)-2,6-diaminohexanoic acid | FAERS: 2 | US FAERS | |
| 6 | Acetylcysteine | FAERS: 2 | US FAERS | |
| 7 | Clozapine | FAERS: 2 | US FAERS | |
| 8 | Iloprost | FAERS: 2 | US FAERS | |
| 9 | Letrozole | FAERS: 2 | US FAERS | |
| 10 | Nicotine | FAERS: 2 | OFFSIDES US FAERS | |
| 11 | Risperidone | FAERS: 2 | US FAERS | |
| 12 | Sildenafil Citrate | FAERS: 2 | US FAERS | |
| 13 | ponatinib | FAERS: 2 | US FAERS | |
| 14 | Atomoxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 15 | Diclofenac | FAERS: 1 | US FAERS | |
| 16 | Dimethyl Fumarate | FAERS: 1 | US FAERS | |
| 17 | Eszopiclone | FAERS: 1 | US FAERS | |
| 18 | Fingolimod Hydrochloride | FAERS: 1 | US FAERS | |
| 19 | Omeprazole | FAERS: 1 | US FAERS | |
| 20 | Quetiapine Fumarate | FAERS: 1 | US FAERS | |
| 21 | Rivastigmine | FAERS: 1 | US FAERS | |
| 22 | Varenicline | FAERS: 1 | US FAERS | |
| 23 | Venlafaxine Hydrochloride | FAERS: 1 | US FAERS | |
| 24 | Zolpidem | FAERS: 1 | US FAERS | |
| 25 | palbociclib | FAERS: 1 | US FAERS | |
| 26 | reviparin | FAERS: 1 | US FAERS | |
| 27 | Carisoprodol | OFFSIDES | ||
| 28 | Danazol | OFFSIDES | ||
| 29 | Formoterol Fumarate | OFFSIDES | ||
| 30 | Lithium | OFFSIDES | ||
| 31 | Meclizine | OFFSIDES | ||
| 32 | Mefloquine | OFFSIDES | ||
| 33 | Ribavirin | OFFSIDES | ||
| 34 | Tretinoin | OFFSIDES | ||
| 35 | tegaserod | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.